Research Alliance Corp. IV IPO
Research Alliance Corp. IV is a special purpose acquisition company (SPAC) focused on identifying and merging with a target business. As a stock-only SPAC structure, it offers equity rather than traditional cash/equity combinations, which may appeal to certain target companies and investors seeking specific deal structures.
Key Facts
| Industry | Special Purpose Acquisition Company (SPAC) |
| Funding | $75 million raised in IPO (July 2026) plus $2.75 million private placement |
About Research Alliance Corp. IV
Research Alliance Corp. IV is a special purpose acquisition company (SPAC), also known as a blank-check company, created to raise capital through an IPO for the purpose of acquiring or merging with an existing private company. The stock-only structure distinguishes it from traditional SPACs that typically offer both cash and equity components in their deals.
SPACs have become an alternative path to public markets for private companies, offering potentially faster timelines and more certain valuations compared to traditional IPOs. The Research Alliance series appears to be a multi-vehicle platform, with this being the fourth iteration. These entities typically have a defined time period (usually 18-24 months) to identify and complete a business combination after going public.
The specific sector focus, target company size, and leadership team for Research Alliance Corp. IV have not been widely disclosed. Like other SPACs, it will raise funds from public investors and hold them in trust until a suitable acquisition target is identified and approved by shareholders.
IPO Status
Research Alliance Corp. IV is a blank-check company (SPAC) that completed its initial public offering on July 14, 2026, raising $75 million. The SPAC is now trading on Nasdaq under the ticker symbol RACD and is focused on identifying and acquiring a company in the healthcare sector. The IPO was accompanied by a $2.75 million private placement and the establishment of a trust account to hold the IPO proceeds. As part of the Research Alliance series of SPACs, Research Alliance Corp. IV follows the typical SPAC structure of raising capital through an IPO with the intent to complete a business combination with a private operating company within a specified timeframe. The company has filed its initial SEC forms including Form 3 filings from officers and directors, and has completed its underwriting agreements. The SPAC will now enter its search phase to identify a suitable acquisition target in the healthcare industry.
Competitors
Frequently Asked Questions
Does Research Alliance Corp. IV have a stock?
Research Alliance Corp. IV has not yet had an IPO. As a SPAC in formation, it is expected to pursue an initial public offering, but no formal filing or completion has occurred. Sign up for alerts to stay informed.
When is the Research Alliance Corp. IV IPO date?
No IPO date has been announced for Research Alliance Corp. IV. The timing of SPAC IPOs depends on market conditions, regulatory approvals, and sponsor readiness. Sign up for alerts to stay informed.
How can I buy Research Alliance Corp. IV stock?
Research Alliance Corp. IV stock is not currently available for purchase as the company has not completed its IPO. Once public, shares would trade on a major exchange under a ticker symbol to be announced. Sign up for alerts to stay informed.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts